Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Vessel Prosthesis | 44 | 2002 | 933 | 2.500 |
Why?
|
Veins | 29 | 2017 | 770 | 2.050 |
Why?
|
Ischemia | 35 | 2017 | 1907 | 1.800 |
Why?
|
Polyethylene Terephthalates | 22 | 2014 | 116 | 1.770 |
Why?
|
Leg | 40 | 2003 | 1116 | 1.770 |
Why?
|
Muscle, Smooth, Vascular | 14 | 2016 | 1503 | 1.690 |
Why?
|
Diabetic Angiopathies | 29 | 2013 | 819 | 1.530 |
Why?
|
Myocytes, Smooth Muscle | 5 | 2014 | 688 | 1.450 |
Why?
|
RNA, Small Interfering | 14 | 2024 | 3504 | 1.440 |
Why?
|
Foot | 21 | 2005 | 527 | 1.210 |
Why?
|
Saphenous Vein | 20 | 2010 | 532 | 1.050 |
Why?
|
Gene Silencing | 6 | 2016 | 1537 | 1.000 |
Why?
|
Hirudins | 8 | 1999 | 183 | 0.940 |
Why?
|
Aorta | 9 | 2016 | 2062 | 0.940 |
Why?
|
Peripheral Vascular Diseases | 12 | 2007 | 549 | 0.900 |
Why?
|
Vascular Surgical Procedures | 26 | 2007 | 1476 | 0.900 |
Why?
|
Biocompatible Materials | 11 | 2010 | 1731 | 0.870 |
Why?
|
Angioplasty | 4 | 2017 | 364 | 0.870 |
Why?
|
Arteries | 17 | 2017 | 1119 | 0.860 |
Why?
|
Limb Salvage | 8 | 2017 | 433 | 0.820 |
Why?
|
Diabetes Complications | 17 | 2007 | 1360 | 0.820 |
Why?
|
Femoral Artery | 29 | 2007 | 845 | 0.810 |
Why?
|
Endothelium, Vascular | 17 | 2012 | 4459 | 0.770 |
Why?
|
Arterial Occlusive Diseases | 18 | 2006 | 793 | 0.740 |
Why?
|
Arm | 13 | 2000 | 588 | 0.700 |
Why?
|
Arteriosclerosis | 16 | 2002 | 1092 | 0.690 |
Why?
|
Vascular Patency | 28 | 2007 | 887 | 0.680 |
Why?
|
Blood Vessel Prosthesis Implantation | 18 | 2014 | 1391 | 0.680 |
Why?
|
Diabetic Foot | 11 | 2005 | 355 | 0.650 |
Why?
|
Diabetic Neuropathies | 13 | 2015 | 400 | 0.640 |
Why?
|
Transfection | 6 | 2016 | 5892 | 0.630 |
Why?
|
Popliteal Artery | 19 | 2006 | 317 | 0.620 |
Why?
|
Polyurethanes | 6 | 2005 | 107 | 0.620 |
Why?
|
Tunica Intima | 9 | 2014 | 463 | 0.610 |
Why?
|
Ciprofloxacin | 7 | 2010 | 314 | 0.600 |
Why?
|
Wound Healing | 10 | 2015 | 2776 | 0.600 |
Why?
|
Graft Occlusion, Vascular | 14 | 2005 | 549 | 0.570 |
Why?
|
Thrombospondins | 3 | 2024 | 200 | 0.570 |
Why?
|
Carotid Stenosis | 6 | 2008 | 854 | 0.560 |
Why?
|
RNA Interference | 5 | 2014 | 2890 | 0.540 |
Why?
|
Lower Extremity | 6 | 2017 | 1158 | 0.540 |
Why?
|
Endarterectomy, Carotid | 6 | 2003 | 546 | 0.530 |
Why?
|
Hyperplasia | 15 | 2024 | 1185 | 0.530 |
Why?
|
Stents | 7 | 2017 | 3280 | 0.510 |
Why?
|
Polyethyleneimine | 2 | 2016 | 64 | 0.500 |
Why?
|
Polytetrafluoroethylene | 12 | 2002 | 233 | 0.500 |
Why?
|
Neuropeptides | 5 | 2013 | 942 | 0.490 |
Why?
|
Carotid Arteries | 11 | 2002 | 949 | 0.490 |
Why?
|
Cell Adhesion | 9 | 2014 | 3144 | 0.470 |
Why?
|
Coated Materials, Biocompatible | 2 | 2014 | 318 | 0.440 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2014 | 2914 | 0.430 |
Why?
|
Dogs | 22 | 2012 | 3911 | 0.430 |
Why?
|
Angioscopy | 4 | 2000 | 49 | 0.430 |
Why?
|
Vascular Diseases | 8 | 2009 | 1161 | 0.420 |
Why?
|
Cell-Matrix Junctions | 1 | 2011 | 23 | 0.410 |
Why?
|
Foot Diseases | 6 | 1992 | 143 | 0.380 |
Why?
|
Thrombin | 7 | 2005 | 598 | 0.380 |
Why?
|
Diabetes Mellitus, Experimental | 3 | 2015 | 1115 | 0.380 |
Why?
|
Cell Movement | 8 | 2011 | 5216 | 0.350 |
Why?
|
Life Tables | 8 | 2017 | 363 | 0.350 |
Why?
|
Anastomosis, Surgical | 11 | 2007 | 987 | 0.350 |
Why?
|
Microcirculation | 12 | 2002 | 1287 | 0.340 |
Why?
|
Polyethylene Glycols | 1 | 2014 | 1181 | 0.310 |
Why?
|
Substance P | 4 | 2015 | 335 | 0.310 |
Why?
|
Bacterial Infections | 4 | 2005 | 1400 | 0.290 |
Why?
|
Decision Support Techniques | 1 | 2017 | 1956 | 0.290 |
Why?
|
Intracranial Embolism | 1 | 2008 | 202 | 0.290 |
Why?
|
Antithrombins | 3 | 1999 | 304 | 0.290 |
Why?
|
Foot Ulcer | 2 | 1999 | 59 | 0.280 |
Why?
|
Peripheral Arterial Disease | 1 | 2017 | 1188 | 0.280 |
Why?
|
Skin Ulcer | 4 | 2013 | 120 | 0.270 |
Why?
|
Device Approval | 1 | 2007 | 163 | 0.270 |
Why?
|
Leiomyomatosis | 1 | 2005 | 70 | 0.260 |
Why?
|
High-Throughput Screening Assays | 1 | 2011 | 944 | 0.260 |
Why?
|
Coronary Vessels | 3 | 2012 | 3106 | 0.250 |
Why?
|
Diabetes Mellitus | 14 | 2011 | 5752 | 0.250 |
Why?
|
Prosthesis-Related Infections | 2 | 2005 | 537 | 0.250 |
Why?
|
Muscle Proteins | 2 | 2001 | 1158 | 0.250 |
Why?
|
Arteriovenous Shunt, Surgical | 6 | 1992 | 277 | 0.250 |
Why?
|
Anti-Infective Agents | 4 | 2010 | 971 | 0.240 |
Why?
|
Vascular Neoplasms | 1 | 2005 | 175 | 0.240 |
Why?
|
Flow Cytometry | 2 | 2012 | 5973 | 0.230 |
Why?
|
Gene Expression | 4 | 2004 | 7793 | 0.230 |
Why?
|
Bandages | 1 | 2005 | 266 | 0.230 |
Why?
|
Vena Cava, Inferior | 3 | 2005 | 439 | 0.230 |
Why?
|
Serum Albumin, Bovine | 6 | 2002 | 324 | 0.230 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2002 | 1874 | 0.230 |
Why?
|
Cerebral Infarction | 1 | 2008 | 1011 | 0.220 |
Why?
|
Polyesters | 2 | 2010 | 362 | 0.220 |
Why?
|
Popliteal Vein | 3 | 2000 | 43 | 0.220 |
Why?
|
Cerebrovascular Disorders | 4 | 1999 | 1504 | 0.220 |
Why?
|
Humans | 169 | 2017 | 743811 | 0.220 |
Why?
|
Coronary Disease | 4 | 2002 | 6078 | 0.210 |
Why?
|
Surface Properties | 8 | 2005 | 1168 | 0.210 |
Why?
|
Cadherins | 1 | 2007 | 907 | 0.210 |
Why?
|
Cysteine Endopeptidases | 2 | 2001 | 563 | 0.210 |
Why?
|
Heart Neoplasms | 1 | 2005 | 374 | 0.210 |
Why?
|
Femoral Vein | 3 | 2000 | 159 | 0.210 |
Why?
|
Gelatin | 1 | 2024 | 226 | 0.210 |
Why?
|
Cell Proliferation | 7 | 2024 | 10477 | 0.210 |
Why?
|
Angioplasty, Balloon | 4 | 2016 | 653 | 0.200 |
Why?
|
Time Factors | 26 | 2017 | 40038 | 0.200 |
Why?
|
Neuropeptide Y | 3 | 2011 | 200 | 0.200 |
Why?
|
Multienzyme Complexes | 2 | 2001 | 686 | 0.200 |
Why?
|
Platelet Activation | 3 | 1995 | 674 | 0.190 |
Why?
|
Blood Coagulation | 2 | 2005 | 1127 | 0.190 |
Why?
|
Cell Division | 5 | 2002 | 4568 | 0.190 |
Why?
|
Venous Cutdown | 1 | 2000 | 6 | 0.180 |
Why?
|
Cytokines | 3 | 2013 | 7324 | 0.180 |
Why?
|
Cells, Cultured | 12 | 2011 | 19232 | 0.180 |
Why?
|
Vascular System Injuries | 1 | 2024 | 250 | 0.180 |
Why?
|
Celiac Artery | 1 | 2000 | 69 | 0.180 |
Why?
|
Gene Expression Regulation | 6 | 2016 | 12066 | 0.180 |
Why?
|
Nuclear Proteins | 2 | 2014 | 5854 | 0.180 |
Why?
|
Heel | 1 | 1999 | 36 | 0.180 |
Why?
|
Aged | 68 | 2017 | 163178 | 0.170 |
Why?
|
Coronary Artery Bypass | 2 | 2014 | 2288 | 0.170 |
Why?
|
Echocardiography, Transesophageal | 1 | 2005 | 1133 | 0.170 |
Why?
|
Vasodilation | 6 | 2002 | 944 | 0.170 |
Why?
|
Estradiol Congeners | 1 | 1998 | 28 | 0.160 |
Why?
|
Certification | 1 | 2002 | 423 | 0.160 |
Why?
|
RNA, Messenger | 7 | 2014 | 13028 | 0.160 |
Why?
|
Blood Flow Velocity | 7 | 1998 | 1423 | 0.160 |
Why?
|
DNA-Binding Proteins | 2 | 2014 | 9648 | 0.150 |
Why?
|
Staphylococcal Infections | 2 | 2005 | 1400 | 0.150 |
Why?
|
Animals | 41 | 2024 | 168660 | 0.150 |
Why?
|
Cell Count | 2 | 2012 | 1855 | 0.150 |
Why?
|
Interleukin-8 | 2 | 2011 | 690 | 0.150 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2004 | 3917 | 0.150 |
Why?
|
Axillary Artery | 3 | 1992 | 50 | 0.150 |
Why?
|
Proteins | 3 | 2001 | 6098 | 0.150 |
Why?
|
Rabbits | 6 | 2015 | 4894 | 0.150 |
Why?
|
Reoperation | 13 | 2007 | 4200 | 0.150 |
Why?
|
Endothelial Cells | 2 | 2011 | 3482 | 0.140 |
Why?
|
Postoperative Complications | 20 | 2007 | 15281 | 0.140 |
Why?
|
Gastric Mucosa | 1 | 2000 | 599 | 0.140 |
Why?
|
Heart Valve Prosthesis | 1 | 2005 | 1489 | 0.140 |
Why?
|
Inflammation | 3 | 2015 | 10629 | 0.140 |
Why?
|
Female | 88 | 2017 | 380020 | 0.140 |
Why?
|
Male | 85 | 2017 | 349776 | 0.140 |
Why?
|
Membrane Proteins | 3 | 2014 | 7880 | 0.140 |
Why?
|
Uterine Neoplasms | 1 | 2005 | 1513 | 0.140 |
Why?
|
Diabetes Mellitus, Type 1 | 6 | 2003 | 3338 | 0.140 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2008 | 9944 | 0.140 |
Why?
|
Carotid Artery Injuries | 1 | 2016 | 96 | 0.140 |
Why?
|
Prostheses and Implants | 3 | 2010 | 1385 | 0.140 |
Why?
|
Rheology | 6 | 1985 | 345 | 0.140 |
Why?
|
Extremities | 5 | 2004 | 867 | 0.130 |
Why?
|
Materials Testing | 4 | 2005 | 866 | 0.130 |
Why?
|
Models, Animal | 4 | 2007 | 2172 | 0.130 |
Why?
|
Retrospective Studies | 39 | 2017 | 77410 | 0.130 |
Why?
|
Regional Blood Flow | 6 | 2000 | 1525 | 0.130 |
Why?
|
Forearm | 6 | 2002 | 409 | 0.130 |
Why?
|
Skin | 8 | 2015 | 4372 | 0.130 |
Why?
|
Receptors, Neurokinin-1 | 2 | 2015 | 129 | 0.130 |
Why?
|
Estrogen Replacement Therapy | 2 | 1999 | 1203 | 0.130 |
Why?
|
Methacrylates | 1 | 2015 | 106 | 0.130 |
Why?
|
Carboxylic Acids | 4 | 2005 | 97 | 0.130 |
Why?
|
Carotid Artery, Internal | 5 | 2003 | 445 | 0.130 |
Why?
|
Models, Anatomic | 3 | 1990 | 690 | 0.120 |
Why?
|
Adsorption | 2 | 2014 | 201 | 0.120 |
Why?
|
Tissue Preservation | 3 | 1992 | 180 | 0.120 |
Why?
|
Follow-Up Studies | 23 | 2006 | 39001 | 0.120 |
Why?
|
Actuarial Analysis | 5 | 1992 | 378 | 0.120 |
Why?
|
Up-Regulation | 4 | 2013 | 4221 | 0.120 |
Why?
|
Methods | 10 | 1996 | 1128 | 0.120 |
Why?
|
Metatarsus | 1 | 1993 | 19 | 0.110 |
Why?
|
Plant Lectins | 1 | 1993 | 104 | 0.110 |
Why?
|
Ultrasonics | 3 | 1991 | 212 | 0.110 |
Why?
|
Gangrene | 5 | 1999 | 82 | 0.110 |
Why?
|
Glycoconjugates | 1 | 1993 | 87 | 0.110 |
Why?
|
Aged, 80 and over | 19 | 2007 | 57744 | 0.110 |
Why?
|
Recombinant Proteins | 7 | 1999 | 6620 | 0.110 |
Why?
|
Wounds and Injuries | 1 | 2005 | 2401 | 0.110 |
Why?
|
Interferon-gamma | 2 | 1999 | 3205 | 0.110 |
Why?
|
Endothelial Growth Factors | 3 | 2002 | 693 | 0.110 |
Why?
|
Middle Aged | 60 | 2011 | 213241 | 0.110 |
Why?
|
Hydrogen-Ion Concentration | 4 | 2015 | 2556 | 0.110 |
Why?
|
Cross-Linking Reagents | 4 | 1997 | 694 | 0.110 |
Why?
|
Cell Shape | 1 | 2014 | 375 | 0.110 |
Why?
|
Brachiocephalic Veins | 1 | 1992 | 23 | 0.110 |
Why?
|
Pulse | 2 | 1986 | 228 | 0.110 |
Why?
|
Microscopy, Electron, Scanning | 6 | 1995 | 960 | 0.110 |
Why?
|
Peripheral Nerves | 1 | 1996 | 466 | 0.110 |
Why?
|
Kidney Failure, Chronic | 4 | 2004 | 2534 | 0.100 |
Why?
|
Lymphokines | 3 | 2002 | 948 | 0.100 |
Why?
|
Survival Analysis | 9 | 2007 | 10251 | 0.100 |
Why?
|
Receptors, Neuropeptide Y | 1 | 2011 | 44 | 0.100 |
Why?
|
Salvage Therapy | 3 | 2000 | 1275 | 0.100 |
Why?
|
Tensile Strength | 3 | 2005 | 335 | 0.100 |
Why?
|
Activities of Daily Living | 2 | 1998 | 2419 | 0.100 |
Why?
|
Angiography | 7 | 1999 | 1638 | 0.100 |
Why?
|
Blood Physiological Phenomena | 1 | 1991 | 55 | 0.100 |
Why?
|
Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2010 | 5 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 10 | 2003 | 11729 | 0.100 |
Why?
|
Protein Binding | 7 | 2001 | 9377 | 0.100 |
Why?
|
Estrogens | 1 | 1998 | 1563 | 0.100 |
Why?
|
Length of Stay | 7 | 2005 | 6311 | 0.100 |
Why?
|
Lectins | 1 | 1993 | 513 | 0.100 |
Why?
|
Air Pressure | 1 | 2010 | 75 | 0.100 |
Why?
|
Nitroprusside | 6 | 2002 | 275 | 0.090 |
Why?
|
Acetylcholine | 7 | 2002 | 619 | 0.090 |
Why?
|
Genes | 1 | 1995 | 1893 | 0.090 |
Why?
|
Tibial Arteries | 3 | 2002 | 57 | 0.090 |
Why?
|
General Surgery | 1 | 2002 | 1636 | 0.090 |
Why?
|
Photomicrography | 1 | 1990 | 74 | 0.090 |
Why?
|
Treatment Outcome | 19 | 2017 | 63042 | 0.090 |
Why?
|
Life Expectancy | 1 | 2017 | 1184 | 0.090 |
Why?
|
Aortic Aneurysm | 2 | 2014 | 644 | 0.090 |
Why?
|
Indicators and Reagents | 1 | 2011 | 462 | 0.090 |
Why?
|
Alloxan | 1 | 2009 | 13 | 0.090 |
Why?
|
Blood Circulation | 2 | 1981 | 251 | 0.090 |
Why?
|
Survival Rate | 11 | 2005 | 12786 | 0.090 |
Why?
|
Prosthesis Design | 4 | 1998 | 2103 | 0.090 |
Why?
|
Creatinine | 3 | 2006 | 1918 | 0.090 |
Why?
|
Fluorescence | 1 | 2012 | 752 | 0.090 |
Why?
|
Carotid Artery Diseases | 4 | 2003 | 875 | 0.090 |
Why?
|
Inflammation Mediators | 3 | 2014 | 1888 | 0.090 |
Why?
|
Tissue Culture Techniques | 1 | 2010 | 291 | 0.090 |
Why?
|
Aneurysm | 2 | 2004 | 339 | 0.090 |
Why?
|
Quality Control | 1 | 2012 | 841 | 0.090 |
Why?
|
Thrombophlebitis | 2 | 1989 | 309 | 0.080 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2011 | 471 | 0.080 |
Why?
|
Iontophoresis | 5 | 2001 | 74 | 0.080 |
Why?
|
Textiles | 3 | 2010 | 46 | 0.080 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1656 | 0.080 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 1991 | 162 | 0.080 |
Why?
|
Risk Factors | 19 | 2017 | 72252 | 0.080 |
Why?
|
Surgical Instruments | 1 | 1991 | 395 | 0.080 |
Why?
|
Macrophages | 4 | 2016 | 5651 | 0.080 |
Why?
|
Tissue Scaffolds | 1 | 2015 | 956 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6539 | 0.080 |
Why?
|
Monitoring, Intraoperative | 2 | 1993 | 957 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 4749 | 0.080 |
Why?
|
Growth Substances | 2 | 2014 | 784 | 0.080 |
Why?
|
Analgesia, Epidural | 1 | 1991 | 326 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2008 | 323 | 0.080 |
Why?
|
Disease-Free Survival | 2 | 2017 | 6895 | 0.080 |
Why?
|
Platelet Aggregation | 4 | 1991 | 798 | 0.080 |
Why?
|
Cloning, Molecular | 3 | 1999 | 4320 | 0.080 |
Why?
|
Calcinosis | 1 | 1996 | 1495 | 0.070 |
Why?
|
Hyperglycemia | 2 | 2011 | 1373 | 0.070 |
Why?
|
Rats, Wistar | 2 | 2015 | 1892 | 0.070 |
Why?
|
Diabetic Nephropathies | 1 | 1994 | 984 | 0.070 |
Why?
|
Hemodynamics | 5 | 1998 | 4197 | 0.070 |
Why?
|
Inguinal Canal | 2 | 2005 | 69 | 0.070 |
Why?
|
Porosity | 2 | 2015 | 360 | 0.070 |
Why?
|
Molecular Chaperones | 2 | 2001 | 742 | 0.070 |
Why?
|
Blotting, Northern | 3 | 1998 | 1581 | 0.070 |
Why?
|
Voluntary Health Agencies | 1 | 1986 | 39 | 0.070 |
Why?
|
Blood Platelets | 3 | 1995 | 2509 | 0.070 |
Why?
|
Transplantation, Autologous | 8 | 2000 | 2123 | 0.070 |
Why?
|
Ultrasonography | 6 | 1996 | 5986 | 0.070 |
Why?
|
Oxygen | 2 | 2015 | 4189 | 0.070 |
Why?
|
Ethylenediamines | 1 | 2005 | 48 | 0.070 |
Why?
|
Contusions | 1 | 1986 | 81 | 0.070 |
Why?
|
Quality of Health Care | 2 | 2009 | 4370 | 0.070 |
Why?
|
Aorta, Abdominal | 5 | 1995 | 646 | 0.070 |
Why?
|
Proteasome Endopeptidase Complex | 3 | 2001 | 1335 | 0.070 |
Why?
|
Intraoperative Care | 4 | 2000 | 767 | 0.070 |
Why?
|
Blotting, Western | 2 | 2007 | 5179 | 0.070 |
Why?
|
Iliac Artery | 2 | 1985 | 364 | 0.070 |
Why?
|
Cell Death | 1 | 2011 | 1705 | 0.070 |
Why?
|
Adult | 38 | 2006 | 213889 | 0.070 |
Why?
|
Spectrophotometry | 1 | 2005 | 313 | 0.060 |
Why?
|
Heart Atria | 1 | 2011 | 1357 | 0.060 |
Why?
|
Methylene Blue | 1 | 2005 | 155 | 0.060 |
Why?
|
Immunohistochemistry | 6 | 2002 | 11360 | 0.060 |
Why?
|
Prosthesis Failure | 4 | 2001 | 1203 | 0.060 |
Why?
|
Polymers | 2 | 2005 | 1621 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 3874 | 0.060 |
Why?
|
Transplantation | 1 | 1986 | 217 | 0.060 |
Why?
|
Spasm | 1 | 1984 | 121 | 0.060 |
Why?
|
Critical Illness | 1 | 2017 | 2670 | 0.060 |
Why?
|
Radiography | 9 | 2004 | 7010 | 0.060 |
Why?
|
Fibrinolytic Agents | 1 | 1994 | 2159 | 0.060 |
Why?
|
Heart Function Tests | 1 | 2005 | 328 | 0.060 |
Why?
|
Neovascularization, Physiologic | 1 | 2011 | 1351 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3229 | 0.060 |
Why?
|
Computational Biology | 1 | 2016 | 3515 | 0.060 |
Why?
|
Vascular Endothelial Growth Factors | 3 | 2002 | 771 | 0.060 |
Why?
|
Models, Chemical | 1 | 2005 | 626 | 0.060 |
Why?
|
Glycoproteins | 2 | 2001 | 2266 | 0.060 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 1903 | 0.060 |
Why?
|
Infection Control | 1 | 2010 | 964 | 0.060 |
Why?
|
Communication | 1 | 2017 | 3748 | 0.060 |
Why?
|
Polyethylenes | 1 | 2005 | 285 | 0.060 |
Why?
|
Chromans | 1 | 2003 | 122 | 0.050 |
Why?
|
Molecular Sequence Data | 4 | 1999 | 18107 | 0.050 |
Why?
|
Registries | 7 | 2005 | 8090 | 0.050 |
Why?
|
Vasodilator Agents | 4 | 2002 | 974 | 0.050 |
Why?
|
Brachial Artery | 3 | 1998 | 369 | 0.050 |
Why?
|
Graft Survival | 5 | 2005 | 3734 | 0.050 |
Why?
|
Lasers | 1 | 1987 | 949 | 0.050 |
Why?
|
Coloring Agents | 3 | 2010 | 565 | 0.050 |
Why?
|
Mesenteric Artery, Superior | 1 | 2002 | 101 | 0.050 |
Why?
|
Recurrence | 4 | 2002 | 8337 | 0.050 |
Why?
|
Cattle | 3 | 1999 | 3917 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2009 | 18027 | 0.050 |
Why?
|
Adenosine Triphosphate | 3 | 1995 | 2029 | 0.050 |
Why?
|
Blood Vessels | 3 | 1985 | 1124 | 0.050 |
Why?
|
Credentialing | 1 | 2002 | 126 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-sis | 2 | 2001 | 251 | 0.050 |
Why?
|
Rats | 3 | 2024 | 24250 | 0.050 |
Why?
|
Complement Inactivator Proteins | 1 | 2001 | 79 | 0.050 |
Why?
|
Health Services Research | 1 | 2009 | 1836 | 0.050 |
Why?
|
Endocarditis, Bacterial | 1 | 2005 | 455 | 0.050 |
Why?
|
MicroRNAs | 1 | 2017 | 3750 | 0.050 |
Why?
|
Iliac Aneurysm | 1 | 2001 | 38 | 0.050 |
Why?
|
Cell Cycle | 2 | 2007 | 2963 | 0.050 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2002 | 437 | 0.050 |
Why?
|
Chi-Square Distribution | 3 | 2005 | 3503 | 0.050 |
Why?
|
Down-Regulation | 2 | 2013 | 3000 | 0.050 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 1999 | 707 | 0.050 |
Why?
|
Platelet-Derived Growth Factor | 2 | 2001 | 625 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 1996 | 2883 | 0.040 |
Why?
|
Forefoot, Human | 1 | 1999 | 32 | 0.040 |
Why?
|
Extracellular Matrix | 2 | 2001 | 1743 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2009 | 3208 | 0.040 |
Why?
|
Thiazolidinediones | 1 | 2003 | 475 | 0.040 |
Why?
|
Nitric Oxide Synthase | 2 | 2002 | 915 | 0.040 |
Why?
|
Videotape Recording | 2 | 1991 | 352 | 0.040 |
Why?
|
Reflex | 1 | 2001 | 365 | 0.040 |
Why?
|
Heart Failure | 5 | 2011 | 10896 | 0.040 |
Why?
|
Vasomotor System | 1 | 1999 | 209 | 0.040 |
Why?
|
Transforming Growth Factor alpha | 1 | 1999 | 135 | 0.040 |
Why?
|
Enzyme Activation | 2 | 2002 | 3701 | 0.040 |
Why?
|
Organ Preservation | 1 | 1981 | 331 | 0.040 |
Why?
|
Microscopy, Electron | 3 | 1992 | 2646 | 0.040 |
Why?
|
Antibodies | 1 | 2007 | 2459 | 0.040 |
Why?
|
Incidence | 4 | 2002 | 20948 | 0.040 |
Why?
|
Chemotaxis | 1 | 2001 | 607 | 0.040 |
Why?
|
Ischemic Attack, Transient | 2 | 2003 | 934 | 0.040 |
Why?
|
Retinoblastoma Protein | 1 | 2002 | 705 | 0.040 |
Why?
|
Endoscopy | 3 | 1995 | 1781 | 0.040 |
Why?
|
Specialty Boards | 1 | 2000 | 227 | 0.040 |
Why?
|
Tyrosine | 1 | 2002 | 1462 | 0.040 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2000 | 282 | 0.040 |
Why?
|
Treatment Failure | 2 | 1995 | 2617 | 0.040 |
Why?
|
Platelet Count | 2 | 1991 | 780 | 0.040 |
Why?
|
Polycarboxylate Cement | 1 | 1997 | 18 | 0.040 |
Why?
|
Drug Stability | 1 | 1998 | 291 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2014 | 3445 | 0.040 |
Why?
|
Laser-Doppler Flowmetry | 1 | 1998 | 242 | 0.040 |
Why?
|
Thrombosis | 8 | 1999 | 2968 | 0.040 |
Why?
|
Intraoperative Period | 2 | 1990 | 520 | 0.040 |
Why?
|
Manometry | 1 | 2000 | 445 | 0.040 |
Why?
|
Biological Availability | 1 | 1998 | 397 | 0.040 |
Why?
|
Wrist | 1 | 1979 | 223 | 0.040 |
Why?
|
Iodine Radioisotopes | 1 | 2001 | 1035 | 0.040 |
Why?
|
DNA Probes | 1 | 1998 | 560 | 0.040 |
Why?
|
Logistic Models | 6 | 2006 | 13404 | 0.040 |
Why?
|
Bioprosthesis | 1 | 1981 | 597 | 0.040 |
Why?
|
Maleimides | 1 | 1997 | 112 | 0.040 |
Why?
|
Mitral Valve | 1 | 2005 | 1491 | 0.040 |
Why?
|
Cytoplasm | 1 | 2001 | 1536 | 0.040 |
Why?
|
Risk Assessment | 2 | 2017 | 23327 | 0.040 |
Why?
|
United States | 7 | 2009 | 69859 | 0.040 |
Why?
|
Residence Characteristics | 2 | 1998 | 2050 | 0.040 |
Why?
|
Rehabilitation Centers | 1 | 1998 | 253 | 0.040 |
Why?
|
Tissue Donors | 1 | 1986 | 2241 | 0.040 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1999 | 599 | 0.040 |
Why?
|
Severity of Illness Index | 4 | 2006 | 15526 | 0.040 |
Why?
|
Ubiquitin | 1 | 2001 | 851 | 0.040 |
Why?
|
Cell Adhesion Molecules | 2 | 1999 | 1602 | 0.040 |
Why?
|
Morbidity | 2 | 2003 | 1768 | 0.030 |
Why?
|
Vertebral Artery | 1 | 1977 | 192 | 0.030 |
Why?
|
Sphincter of Oddi | 1 | 1975 | 22 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2000 | 1108 | 0.030 |
Why?
|
Cohort Studies | 8 | 2005 | 40545 | 0.030 |
Why?
|
Homes for the Aged | 1 | 1998 | 260 | 0.030 |
Why?
|
Models, Biological | 3 | 1982 | 9582 | 0.030 |
Why?
|
Hemostasis, Surgical | 1 | 1996 | 128 | 0.030 |
Why?
|
Thiazoles | 1 | 2003 | 1482 | 0.030 |
Why?
|
Base Sequence | 2 | 1999 | 12798 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2014 | 19894 | 0.030 |
Why?
|
Endothelium | 3 | 1983 | 777 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 4422 | 0.030 |
Why?
|
Aorta, Thoracic | 2 | 1999 | 1084 | 0.030 |
Why?
|
Models, Cardiovascular | 1 | 1980 | 996 | 0.030 |
Why?
|
Ampulla of Vater | 1 | 1975 | 141 | 0.030 |
Why?
|
GATA4 Transcription Factor | 1 | 2016 | 131 | 0.030 |
Why?
|
Medicare | 1 | 1993 | 6565 | 0.030 |
Why?
|
Phenotype | 2 | 2008 | 16361 | 0.030 |
Why?
|
Staphylococcus aureus | 2 | 1993 | 1453 | 0.030 |
Why?
|
Intestinal Polyps | 1 | 1975 | 99 | 0.030 |
Why?
|
Hyperbaric Oxygenation | 1 | 1996 | 163 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2006 | 3778 | 0.030 |
Why?
|
Decompression, Surgical | 1 | 2000 | 594 | 0.030 |
Why?
|
Stroke Volume | 1 | 2007 | 5002 | 0.030 |
Why?
|
Biliary Tract Diseases | 1 | 1975 | 161 | 0.030 |
Why?
|
Menstrual Cycle | 1 | 1998 | 551 | 0.030 |
Why?
|
Chromogenic Compounds | 1 | 1994 | 30 | 0.030 |
Why?
|
Kidney Transplantation | 3 | 2003 | 4251 | 0.030 |
Why?
|
Ethics, Medical | 1 | 2000 | 792 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 2 | 2005 | 2267 | 0.030 |
Why?
|
Evaluation Studies as Topic | 3 | 1999 | 1677 | 0.030 |
Why?
|
Ophthalmic Artery | 1 | 1974 | 60 | 0.030 |
Why?
|
alpha 1-Antitrypsin | 1 | 1995 | 163 | 0.030 |
Why?
|
Blood Cell Count | 1 | 1995 | 403 | 0.030 |
Why?
|
Hematoma | 1 | 1999 | 758 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2001 | 2123 | 0.030 |
Why?
|
Plasminogen | 1 | 1994 | 152 | 0.030 |
Why?
|
Cyclins | 1 | 1996 | 603 | 0.030 |
Why?
|
Serum Albumin | 1 | 1997 | 675 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2002 | 3510 | 0.030 |
Why?
|
Chromatography, Gel | 1 | 1994 | 670 | 0.030 |
Why?
|
Perfusion | 1 | 1998 | 1359 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1995 | 1085 | 0.030 |
Why?
|
Papaverine | 2 | 1984 | 45 | 0.030 |
Why?
|
Hydrolysis | 1 | 1995 | 683 | 0.030 |
Why?
|
Renal Dialysis | 5 | 2006 | 1783 | 0.030 |
Why?
|
Biomedical Research | 1 | 2009 | 3308 | 0.030 |
Why?
|
Drug Interactions | 1 | 1998 | 1460 | 0.030 |
Why?
|
Syndrome | 1 | 2000 | 3249 | 0.030 |
Why?
|
Quality of Life | 1 | 1995 | 12788 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2015 | 676 | 0.030 |
Why?
|
Myocardial Infarction | 4 | 2005 | 11708 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2016 | 637 | 0.030 |
Why?
|
Growth Inhibitors | 1 | 2014 | 385 | 0.030 |
Why?
|
Amputation Stumps | 1 | 1993 | 39 | 0.030 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1993 | 220 | 0.030 |
Why?
|
Sulfhydryl Compounds | 1 | 1994 | 298 | 0.030 |
Why?
|
Finite Element Analysis | 1 | 2015 | 428 | 0.030 |
Why?
|
Creatine Kinase | 1 | 1995 | 694 | 0.030 |
Why?
|
Case-Control Studies | 4 | 1999 | 21733 | 0.030 |
Why?
|
Axons | 1 | 2001 | 1685 | 0.030 |
Why?
|
Intraoperative Complications | 2 | 2007 | 1195 | 0.030 |
Why?
|
Ileum | 1 | 1975 | 565 | 0.030 |
Why?
|
Intestinal Neoplasms | 1 | 1975 | 319 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 2 | 2001 | 1870 | 0.030 |
Why?
|
Collagen | 2 | 2016 | 2681 | 0.030 |
Why?
|
Retinoblastoma | 1 | 1995 | 316 | 0.030 |
Why?
|
Leg Injuries | 2 | 1985 | 178 | 0.030 |
Why?
|
Bacterial Adhesion | 1 | 1993 | 316 | 0.030 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2002 | 1187 | 0.030 |
Why?
|
Hot Temperature | 2 | 1998 | 1351 | 0.030 |
Why?
|
Autoantigens | 1 | 1996 | 892 | 0.030 |
Why?
|
Interleukin-1 | 1 | 2016 | 1263 | 0.030 |
Why?
|
Dipeptides | 1 | 1994 | 409 | 0.030 |
Why?
|
Intermittent Claudication | 3 | 2000 | 309 | 0.030 |
Why?
|
DNA, Complementary | 1 | 1995 | 2050 | 0.020 |
Why?
|
Peptide Hydrolases | 1 | 2014 | 633 | 0.020 |
Why?
|
Clusterin | 2 | 2001 | 72 | 0.020 |
Why?
|
Genetic Techniques | 1 | 2014 | 435 | 0.020 |
Why?
|
Radiology, Interventional | 1 | 1995 | 460 | 0.020 |
Why?
|
Nursing Homes | 1 | 1998 | 1036 | 0.020 |
Why?
|
Filtration | 2 | 1982 | 233 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 1998 | 1372 | 0.020 |
Why?
|
Patient Admission | 1 | 1998 | 1380 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 1994 | 13809 | 0.020 |
Why?
|
Thromboxane B2 | 1 | 1990 | 152 | 0.020 |
Why?
|
Chemical Industry | 1 | 2010 | 114 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1994 | 1574 | 0.020 |
Why?
|
Protease Inhibitors | 1 | 2014 | 792 | 0.020 |
Why?
|
Heart Diseases | 2 | 2004 | 2789 | 0.020 |
Why?
|
Fibrinolysis | 1 | 1991 | 322 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 1996 | 805 | 0.020 |
Why?
|
Boston | 3 | 2004 | 9310 | 0.020 |
Why?
|
Prospective Studies | 6 | 2006 | 53250 | 0.020 |
Why?
|
Postoperative Period | 2 | 2006 | 1841 | 0.020 |
Why?
|
Platelet Adhesiveness | 1 | 1990 | 161 | 0.020 |
Why?
|
Therapeutic Irrigation | 1 | 1991 | 300 | 0.020 |
Why?
|
Substrate Specificity | 1 | 1994 | 1802 | 0.020 |
Why?
|
Dermis | 1 | 2011 | 207 | 0.020 |
Why?
|
Tissue Engineering | 2 | 2015 | 1880 | 0.020 |
Why?
|
Cause of Death | 1 | 2000 | 3580 | 0.020 |
Why?
|
Cell Survival | 2 | 2015 | 5881 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2014 | 1227 | 0.020 |
Why?
|
Transcription, Genetic | 3 | 2002 | 7719 | 0.020 |
Why?
|
Fiber Optic Technology | 1 | 1991 | 290 | 0.020 |
Why?
|
Stroke | 3 | 2003 | 9975 | 0.020 |
Why?
|
Sex Factors | 2 | 2000 | 10394 | 0.020 |
Why?
|
Transcription Factors | 2 | 2014 | 12209 | 0.020 |
Why?
|
Smoking | 2 | 2000 | 8984 | 0.020 |
Why?
|
Thrombectomy | 1 | 1994 | 680 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2000 | 3038 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 2006 | 0.020 |
Why?
|
Hemostasis | 1 | 1991 | 458 | 0.020 |
Why?
|
Oligopeptides | 1 | 1994 | 1188 | 0.020 |
Why?
|
Reference Values | 3 | 2002 | 4974 | 0.020 |
Why?
|
Cell Cycle Proteins | 2 | 2014 | 3463 | 0.020 |
Why?
|
Genomics | 1 | 2004 | 5714 | 0.020 |
Why?
|
Solubility | 2 | 1999 | 1088 | 0.020 |
Why?
|
Random Allocation | 1 | 1992 | 2429 | 0.020 |
Why?
|
Capillaries | 1 | 1991 | 773 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 1975 | 1256 | 0.020 |
Why?
|
Risk | 2 | 1999 | 9677 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 1993 | 1680 | 0.020 |
Why?
|
Reimbursement Mechanisms | 1 | 1993 | 670 | 0.020 |
Why?
|
Microvessels | 1 | 2011 | 544 | 0.020 |
Why?
|
Colon | 1 | 1975 | 1772 | 0.020 |
Why?
|
Kinetics | 1 | 1994 | 6476 | 0.020 |
Why?
|
Necrosis | 1 | 1990 | 1642 | 0.020 |
Why?
|
Age Factors | 2 | 2000 | 18355 | 0.020 |
Why?
|
von Willebrand Factor | 2 | 1999 | 669 | 0.020 |
Why?
|
Anesthesia | 1 | 1997 | 1562 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 1995 | 6170 | 0.020 |
Why?
|
Binding Sites | 1 | 1994 | 6111 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1991 | 3128 | 0.020 |
Why?
|
Obesity | 1 | 2007 | 12744 | 0.020 |
Why?
|
Retroperitoneal Space | 1 | 1985 | 176 | 0.020 |
Why?
|
Ankle | 2 | 1978 | 327 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2014 | 1580 | 0.020 |
Why?
|
Research Support as Topic | 1 | 2009 | 705 | 0.020 |
Why?
|
Suture Techniques | 1 | 1989 | 797 | 0.020 |
Why?
|
Fasting | 2 | 2003 | 1590 | 0.020 |
Why?
|
Surgical Equipment | 1 | 1984 | 57 | 0.020 |
Why?
|
Ureteral Obstruction | 1 | 1986 | 296 | 0.020 |
Why?
|
Cell Membrane | 1 | 2014 | 3749 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2001 | 11478 | 0.010 |
Why?
|
Fibula | 1 | 1986 | 268 | 0.010 |
Why?
|
Proteinuria | 1 | 2006 | 658 | 0.010 |
Why?
|
Arm Injuries | 1 | 1985 | 160 | 0.010 |
Why?
|
Patient Selection | 1 | 1996 | 4210 | 0.010 |
Why?
|
Mice | 3 | 2015 | 81154 | 0.010 |
Why?
|
Computers | 1 | 1986 | 602 | 0.010 |
Why?
|
Leg Ulcer | 2 | 1997 | 69 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1992 | 6356 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3591 | 0.010 |
Why?
|
Hospital Mortality | 1 | 1997 | 5316 | 0.010 |
Why?
|
Prognosis | 4 | 2006 | 29052 | 0.010 |
Why?
|
Blood Pressure | 5 | 1978 | 8551 | 0.010 |
Why?
|
Venae Cavae | 1 | 1982 | 41 | 0.010 |
Why?
|
Protein Conformation | 1 | 1991 | 4009 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2014 | 2217 | 0.010 |
Why?
|
Los Angeles | 1 | 2002 | 238 | 0.010 |
Why?
|
Nuclear Matrix | 1 | 2001 | 28 | 0.010 |
Why?
|
E2F1 Transcription Factor | 1 | 2002 | 190 | 0.010 |
Why?
|
Buffers | 1 | 2001 | 147 | 0.010 |
Why?
|
E2F Transcription Factors | 1 | 2002 | 277 | 0.010 |
Why?
|
Textile Industry | 1 | 2001 | 74 | 0.010 |
Why?
|
Health Status | 1 | 1995 | 4031 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 35409 | 0.010 |
Why?
|
Immunoglobulins | 1 | 1984 | 881 | 0.010 |
Why?
|
Neutrophils | 1 | 1993 | 3718 | 0.010 |
Why?
|
Umbilical Veins | 1 | 2001 | 433 | 0.010 |
Why?
|
Canada | 1 | 1986 | 2064 | 0.010 |
Why?
|
Myocardial Revascularization | 1 | 2005 | 841 | 0.010 |
Why?
|
Pulmonary Embolism | 3 | 1982 | 2375 | 0.010 |
Why?
|
Tibia | 1 | 1986 | 1077 | 0.010 |
Why?
|
Cytomegalovirus | 1 | 1984 | 733 | 0.010 |
Why?
|
Hypertension | 1 | 2000 | 8480 | 0.010 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2002 | 689 | 0.010 |
Why?
|
Culture Media | 1 | 1981 | 909 | 0.010 |
Why?
|
Adolescent | 6 | 2004 | 85729 | 0.010 |
Why?
|
Sodium Chloride | 1 | 1981 | 625 | 0.010 |
Why?
|
Massachusetts | 1 | 1992 | 8660 | 0.010 |
Why?
|
Equipment Failure Analysis | 1 | 2001 | 864 | 0.010 |
Why?
|
Aneurysm, Ruptured | 1 | 2004 | 452 | 0.010 |
Why?
|
Patient Readmission | 1 | 1993 | 3117 | 0.010 |
Why?
|
Immunoblotting | 1 | 2002 | 1683 | 0.010 |
Why?
|
Equipment and Supplies | 1 | 1981 | 281 | 0.010 |
Why?
|
Biopsy | 2 | 2002 | 6750 | 0.010 |
Why?
|
Peroneal Nerve | 1 | 1998 | 74 | 0.010 |
Why?
|
Placebos | 1 | 2003 | 1674 | 0.010 |
Why?
|
Ethyldimethylaminopropyl Carbodiimide | 1 | 1997 | 3 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 7908 | 0.010 |
Why?
|
Butylene Glycols | 1 | 1997 | 10 | 0.010 |
Why?
|
Hydroxy Acids | 1 | 1997 | 18 | 0.010 |
Why?
|
Delayed-Action Preparations | 1 | 2001 | 967 | 0.010 |
Why?
|
Pliability | 1 | 1997 | 63 | 0.010 |
Why?
|
Chemistry, Physical | 1 | 1997 | 156 | 0.010 |
Why?
|
Doppler Effect | 1 | 1977 | 13 | 0.010 |
Why?
|
Endothelin-1 | 1 | 1999 | 314 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2005 | 12354 | 0.010 |
Why?
|
Fibronectins | 1 | 2001 | 726 | 0.010 |
Why?
|
Subclavian Steal Syndrome | 1 | 1977 | 23 | 0.010 |
Why?
|
Chemical Phenomena | 1 | 1997 | 518 | 0.010 |
Why?
|
Extracellular Matrix Proteins | 1 | 2001 | 850 | 0.010 |
Why?
|
Pressure | 1 | 1980 | 1205 | 0.010 |
Why?
|
Societies, Medical | 1 | 2009 | 3740 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2009 | 3608 | 0.010 |
Why?
|
Propionates | 1 | 1997 | 169 | 0.010 |
Why?
|
Neural Conduction | 1 | 1998 | 441 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 1998 | 458 | 0.010 |
Why?
|
Receptors, Immunologic | 1 | 2002 | 1423 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2002 | 2369 | 0.010 |
Why?
|
Blood Viscosity | 1 | 1976 | 124 | 0.010 |
Why?
|
Ultrasonography, Interventional | 1 | 2004 | 1486 | 0.010 |
Why?
|
Membranes, Artificial | 1 | 1997 | 371 | 0.010 |
Why?
|
Antigens, Nuclear | 1 | 1996 | 193 | 0.010 |
Why?
|
Ulcer | 1 | 1977 | 209 | 0.010 |
Why?
|
Health Care Costs | 1 | 2009 | 3207 | 0.010 |
Why?
|
Preoperative Care | 1 | 2005 | 2251 | 0.010 |
Why?
|
Elasticity | 1 | 1997 | 657 | 0.010 |
Why?
|
Forecasting | 1 | 2005 | 2950 | 0.010 |
Why?
|
Albuminuria | 1 | 1999 | 681 | 0.010 |
Why?
|
Permeability | 1 | 1997 | 738 | 0.010 |
Why?
|
Premenopause | 1 | 1999 | 1033 | 0.010 |
Why?
|
Temperature | 1 | 1981 | 2202 | 0.010 |
Why?
|
Specialties, Surgical | 1 | 2000 | 391 | 0.010 |
Why?
|
Blood | 1 | 1997 | 596 | 0.010 |
Why?
|
Embolism | 1 | 1978 | 407 | 0.010 |
Why?
|
Anesthesia, Epidural | 1 | 1997 | 228 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 1984 | 2278 | 0.010 |
Why?
|
Surgical Wound Infection | 1 | 2004 | 1539 | 0.010 |
Why?
|
Ki-67 Antigen | 1 | 1996 | 644 | 0.010 |
Why?
|
Endarterectomy | 1 | 1974 | 195 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2001 | 1677 | 0.010 |
Why?
|
Anesthesia, Spinal | 1 | 1997 | 269 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2002 | 2969 | 0.010 |
Why?
|
Motor Neurons | 1 | 1998 | 841 | 0.010 |
Why?
|
Disease Progression | 2 | 2002 | 13273 | 0.010 |
Why?
|
Graft Rejection | 1 | 1986 | 4398 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1998 | 1213 | 0.010 |
Why?
|
Anesthesia, General | 2 | 1997 | 1171 | 0.010 |
Why?
|
Confidence Intervals | 1 | 1998 | 2971 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2004 | 1917 | 0.010 |
Why?
|
Duodenum | 1 | 1975 | 484 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 1997 | 1684 | 0.010 |
Why?
|
Pneumonia | 1 | 2004 | 2133 | 0.010 |
Why?
|
Myocardial Contraction | 1 | 1977 | 1579 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2002 | 4326 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2009 | 7270 | 0.010 |
Why?
|
Neuralgia | 1 | 1998 | 570 | 0.010 |
Why?
|
Water | 1 | 1997 | 1394 | 0.010 |
Why?
|
Surgery, Plastic | 1 | 1978 | 624 | 0.010 |
Why?
|
Ethanol | 1 | 1997 | 1343 | 0.010 |
Why?
|
Postmenopause | 1 | 1999 | 2458 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2000 | 2715 | 0.010 |
Why?
|
Wounds, Gunshot | 1 | 1976 | 563 | 0.010 |
Why?
|
Body Mass Index | 1 | 2007 | 12718 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 10940 | 0.010 |
Why?
|
Comorbidity | 1 | 2004 | 10380 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2002 | 12243 | 0.000 |
Why?
|
Insulin | 1 | 2003 | 6584 | 0.000 |
Why?
|
Gene Expression Profiling | 1 | 2004 | 9440 | 0.000 |
Why?
|
Acute Disease | 1 | 1998 | 7150 | 0.000 |
Why?
|
RNA | 1 | 1997 | 2748 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2002 | 15067 | 0.000 |
Why?
|
Glucose | 1 | 1998 | 4398 | 0.000 |
Why?
|
Odds Ratio | 1 | 1998 | 9848 | 0.000 |
Why?
|
Hemagglutination Tests | 1 | 1984 | 75 | 0.000 |
Why?
|
Dilatation | 1 | 1986 | 291 | 0.000 |
Why?
|
Algorithms | 1 | 2005 | 13869 | 0.000 |
Why?
|
Pain | 1 | 1977 | 4987 | 0.000 |
Why?
|
Catheterization | 1 | 1986 | 1469 | 0.000 |
Why?
|
Jugular Veins | 1 | 1981 | 204 | 0.000 |
Why?
|
Cytomegalovirus Infections | 1 | 1984 | 820 | 0.000 |
Why?
|
Constriction | 1 | 1977 | 181 | 0.000 |
Why?
|
Fluoroscopy | 1 | 1981 | 924 | 0.000 |
Why?
|
Blood Volume | 1 | 1977 | 565 | 0.000 |
Why?
|
Cardiac Output | 1 | 1977 | 854 | 0.000 |
Why?
|
Wounds, Penetrating | 1 | 1976 | 307 | 0.000 |
Why?
|
Antibodies, Viral | 1 | 1984 | 3175 | 0.000 |
Why?
|
Neoplasms | 1 | 1982 | 21675 | 0.000 |
Why?
|
Hypotension | 1 | 1977 | 884 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1986 | 12954 | 0.000 |
Why?
|
Fractures, Bone | 1 | 1982 | 1946 | 0.000 |
Why?
|
Anticoagulants | 1 | 1982 | 4599 | 0.000 |
Why?
|
Child | 2 | 1983 | 77637 | 0.000 |
Why?
|
Infant | 1 | 1983 | 35122 | 0.000 |
Why?
|
Child, Preschool | 1 | 1983 | 40964 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 1977 | 15142 | 0.000 |
Why?
|